Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis

Joy Melnikow, Stephen Birch, Christina Slee, Theodore J McCarthy, L Jay Helms, Miriam Kuppermann

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Nursing and Health Professions